Literature DB >> 24923445

The tumor suppressor chromodomain helicase DNA-binding protein 5 (CHD5) remodels nucleosomes by unwrapping.

Jinhua Quan, Timur Yusufzai.   

Abstract

Although mutations or deletions of chromodomain helicase DNA-binding protein 5 (CHD5) have been linked to cancer and implicate CHD5 in tumor suppression, the ATP-dependent activity of CHD5 is currently unknown. In this study, we discovered that CHD5 is a chromatin remodeling factor with a unique enzymatic activity. CHD5 can expose nucleosomal DNA at one or two discrete positions in the nucleosome. The exposure of the nucleosomal DNA by CHD5 is dependent on ATP hydrolysis, but continued ATP hydrolysis is not required to maintain the nucleosomes in their remodeled state. The activity of CHD5 is distinct from other related chromatin remodeling ATPases, such as ACF and BRG1, and does not lead to complete disruption or destabilization of the nucleosome. Rather, CHD5 likely initiates remodeling in a manner similar to that of other remodeling factors but does not significantly reposition the nucleosome. While the related factor CHD4 shows strong ATPase activity, it does not unwrap nucleosomes as efficiently as CHD5. Our findings add to the growing evidence that chromatin remodeling ATPases have diverse roles in modulating chromatin structure.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24923445      PMCID: PMC4110282          DOI: 10.1074/jbc.M114.568568

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Functional delineation of three groups of the ATP-dependent family of chromatin remodeling enzymes.

Authors:  L A Boyer; C Logie; E Bonte; P B Becker; P A Wade; A P Wolffe; C Wu; A N Imbalzano; C L Peterson
Journal:  J Biol Chem       Date:  2000-06-23       Impact factor: 5.157

2.  SWI/SNF has intrinsic nucleosome disassembly activity that is dependent on adjacent nucleosomes.

Authors:  Mekonnen Lemma Dechassa; Abdellah Sabri; Santhi Pondugula; Stefan R Kassabov; Nilanjana Chatterjee; Michael P Kladde; Blaine Bartholomew
Journal:  Mol Cell       Date:  2010-05-28       Impact factor: 17.970

3.  Chd5 requires PHD-mediated histone 3 binding for tumor suppression.

Authors:  Shilpi Paul; Alex Kuo; Thomas Schalch; Hannes Vogel; Leemor Joshua-Tor; W Richard McCombie; Or Gozani; Molly Hammell; Alea A Mills
Journal:  Cell Rep       Date:  2013-01-10       Impact factor: 9.423

4.  Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.

Authors:  Liang Wang; Shiming He; Yanyang Tu; Peigang Ji; Jianhai Zong; Jingyu Zhang; Fuqiang Feng; Jipei Zhao; Guodong Gao; Yongsheng Zhang
Journal:  J Clin Neurosci       Date:  2013-05-23       Impact factor: 1.961

5.  Multivalent recognition of histone tails by the PHD fingers of CHD5.

Authors:  Samuel S Oliver; Catherine A Musselman; Rajini Srinivasan; John P Svaren; Tatiana G Kutateladze; John M Denu
Journal:  Biochemistry       Date:  2012-08-08       Impact factor: 3.162

Review 6.  Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions.

Authors:  J A Eisen; K S Sweder; P C Hanawalt
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

7.  HMGN proteins act in opposition to ATP-dependent chromatin remodeling factors to restrict nucleosome mobility.

Authors:  Barbara P Rattner; Timur Yusufzai; James T Kadonaga
Journal:  Mol Cell       Date:  2009-06-12       Impact factor: 17.970

8.  Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma.

Authors:  Idoia Garcia; Gemma Mayol; Eva Rodríguez; Mariona Suñol; Timothy R Gershon; José Ríos; Nai-Kong V Cheung; Mark W Kieran; Rani E George; Antonio R Perez-Atayde; Carla Casala; Patricia Galván; Carmen de Torres; Jaume Mora; Cinzia Lavarino
Journal:  Mol Cancer       Date:  2010-10-15       Impact factor: 27.401

9.  CHD5, a brain-specific paralog of Mi2 chromatin remodeling enzymes, regulates expression of neuronal genes.

Authors:  Rebecca Casaday Potts; Peisu Zhang; Andrea L Wurster; Patricia Precht; Mohamed R Mughal; William H Wood; Yonqing Zhang; Kevin G Becker; Mark P Mattson; Michael J Pazin
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

10.  ATP-dependent chromatin remodeling by Cockayne syndrome protein B and NAP1-like histone chaperones is required for efficient transcription-coupled DNA repair.

Authors:  Iltaeg Cho; Pei-Fang Tsai; Robert J Lake; Asjad Basheer; Hua-Ying Fan
Journal:  PLoS Genet       Date:  2013-04-18       Impact factor: 5.917

View more
  11 in total

Review 1.  Chromodomain helicase DNA-binding proteins in stem cells and human developmental diseases.

Authors:  Joseph A Micucci; Ethan D Sperry; Donna M Martin
Journal:  Stem Cells Dev       Date:  2015-02-25       Impact factor: 3.272

Review 2.  The Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer.

Authors:  Alea A Mills
Journal:  Cold Spring Harb Perspect Med       Date:  2017-04-03       Impact factor: 6.915

Review 3.  Regulation of neuronal connectivity in the mammalian brain by chromatin remodeling.

Authors:  Jared V Goodman; Azad Bonni
Journal:  Curr Opin Neurobiol       Date:  2019-05-28       Impact factor: 6.627

4.  Human CHD2 is a chromatin assembly ATPase regulated by its chromo- and DNA-binding domains.

Authors:  Jessica C Liu; Catarina G Ferreira; Timur Yusufzai
Journal:  J Biol Chem       Date:  2014-11-10       Impact factor: 5.157

5.  The ATP-dependent chromatin remodeling enzymes CHD6, CHD7, and CHD8 exhibit distinct nucleosome binding and remodeling activities.

Authors:  Benjamin J Manning; Timur Yusufzai
Journal:  J Biol Chem       Date:  2017-05-21       Impact factor: 5.157

6.  Defining the transcriptomic landscape of the developing enteric nervous system and its cellular environment.

Authors:  Sweta Roy-Carson; Kevin Natukunda; Hsien-Chao Chou; Narinder Pal; Caitlin Farris; Stephan Q Schneider; Julie A Kuhlman
Journal:  BMC Genomics       Date:  2017-04-12       Impact factor: 3.969

7.  De novo and inherited private variants in MAP1B in periventricular nodular heterotopia.

Authors:  Erin L Heinzen; Adam C O'Neill; Xiaolin Zhu; Andrew S Allen; Melanie Bahlo; Jamel Chelly; Ming Hui Chen; William B Dobyns; Saskia Freytag; Renzo Guerrini; Richard J Leventer; Annapurna Poduri; Stephen P Robertson; Christopher A Walsh; Mengqi Zhang
Journal:  PLoS Genet       Date:  2018-05-08       Impact factor: 5.917

8.  CHD5 inhibits metastasis of neuroblastoma.

Authors:  Astrid K Laut; Carmen Dorneburg; Axel Fürstberger; Thomas F E Barth; Hans A Kestler; Klaus-Michael Debatin; Christian Beltinger
Journal:  Oncogene       Date:  2021-11-17       Impact factor: 9.867

9.  The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1.

Authors:  Jinhua Quan; Guillaume Adelmant; Jarrod A Marto; A Thomas Look; Timur Yusufzai
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

10.  Chromatin-mediated translational control is essential for neural cell fate specification.

Authors:  Dong-Woo Hwang; Anbalagan Jaganathan; Padmina Shrestha; Ying Jin; Nour El-Amine; Sidney H Wang; Molly Hammell; Alea A Mills
Journal:  Life Sci Alliance       Date:  2018-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.